Accuracy of Pulse Oximeter With Profound Hypoxia
1 other identifier
interventional
12
1 country
1
Brief Summary
Clinical evaluation of the accuracy of SpO2 measurements with the ANNE Limb Sensor compared to blood gas analysis in healthy, adult subjects. Hypoxia is induced in patients to different and stable levels of SaO2 over the range of 70-100%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2021
CompletedFirst Submitted
Initial submission to the registry
December 27, 2022
CompletedFirst Posted
Study publicly available on registry
January 20, 2023
CompletedJanuary 20, 2023
January 1, 2023
1 day
December 27, 2022
January 12, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
ARMS of SpO2 Measurements with ANNE Limb compared to SaO2
Root mean square error between the function blood oxygen saturation (SpO2) provided by the device under test and the blood gas analysis of oxyhemoglobin saturation (SaO2)
1 hour
Study Arms (1)
Comparison of ANNE Limb Sensor pulse oximetry measurements to blood gas analysis
EXPERIMENTALInterventions
Pulse Oximeter
Eligibility Criteria
You may qualify if:
- The subject is male or female, between the ages of 18 and 55 years.
- The subject is in good general health with no evidence of any medical problems
- The subject is fluent in both written and spoken English
- The subject has provided informed consent and is willing to comply with the study procedures.
You may not qualify if:
- Known history of heart disease, lung disease, kidney or liver disease
- Diagnosis of asthma, sleep apnea, or use of CPAP
- Subject has diabetes
- Subject has a clotting disorder
- The subject has a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation
- The subject has any other serious systemic illness
- Th subject is a current smoker
- Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators would interfere with the sensors working correctly
- The subject has a history of fainting or vasovagal response
- The subject has a history of sensitivity to local anesthesia
- The subject has a diagnosis of Raynaud's disease
- The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test)
- The subject is pregnant, lactating, or trying to get pregnant
- The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures
- The subject has any other condition, which in the opinion of the investigators would make them unsuitable for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hypoxia Research Laboratory Department of Anesthesia and Perioperative Care University of California, San Francisco
San Francisco, California, 94143, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2022
First Posted
January 20, 2023
Study Start
June 23, 2021
Primary Completion
June 24, 2021
Study Completion
June 24, 2021
Last Updated
January 20, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share